CABASER

Cabaser Adverse Events Reported to the FDA Over Time

How are Cabaser adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cabaser, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cabaser is flagged as the suspect drug causing the adverse event.

Most Common Cabaser Adverse Events Reported to the FDA

What are the most common Cabaser adverse events reported to the FDA?

Mitral Valve Incompetence	23 (3.26%)
Aortic Valve Incompetence	21 (2.98%)
Cardiac Valve Disease	19 (2.7%)
Pleural Effusion	19 (2.7%)
Hallucination	16 (2.27%)
Pleurisy	15 (2.13%)
Neuroleptic Malignant Syndrome	13 (1.84%)
Dyspnoea	12 (1.7%)
Pneumonia	11 (1.56%)
Cardiac Failure	10 (1.42%)
Fall	10 (1.42%)
	Show More
Interstitial Lung Disease	10 (1.42%)
Delirium	9 (1.28%)
Delusion	7 (.99%)
Hypertension	7 (.99%)
Hypoglycaemia	7 (.99%)
Oedema Peripheral	7 (.99%)
Paranoia	7 (.99%)
Persecutory Delusion	7 (.99%)
Tremor	7 (.99%)
Blood Pressure Decreased	6 (.85%)
Hallucination, Auditory	6 (.85%)
Heart Valve Incompetence	6 (.85%)
Mitral Valve Disease	6 (.85%)
Agitation	5 (.71%)
Death	5 (.71%)
Fatigue	5 (.71%)
Fibrosis	5 (.71%)
Respiratory Failure	5 (.71%)
Aggression	4 (.57%)
Bradycardia	4 (.57%)
Coma	4 (.57%)
Confusional State	4 (.57%)
Erectile Dysfunction	4 (.57%)
Gait Disturbance	4 (.57%)
Impulsive Behaviour	4 (.57%)
Insomnia	4 (.57%)
Obsessive-compulsive Disorder	4 (.57%)
Pathological Gambling	4 (.57%)
Pneumonia Aspiration	4 (.57%)
Rapid Eye Movements Sleep Abnormal	4 (.57%)
Sexual Dysfunction	4 (.57%)
Sudden Onset Of Sleep	4 (.57%)
Suicide Attempt	4 (.57%)
Tricuspid Valve Incompetence	4 (.57%)
Abnormal Behaviour	3 (.43%)
Activities Of Daily Living Impaired	3 (.43%)
Aortic Valve Stenosis	3 (.43%)
Blood Albumin Decreased	3 (.43%)
Cardiac Failure Congestive	3 (.43%)
Cardiac Hypertrophy	3 (.43%)
Cardiac Valve Sclerosis	3 (.43%)
Cardiomegaly	3 (.43%)
Condition Aggravated	3 (.43%)
Depressed Level Of Consciousness	3 (.43%)
Drug Administration Error	3 (.43%)
Drug Exposure During Pregnancy	3 (.43%)
Drug Interaction	3 (.43%)
Haemolytic Anaemia	3 (.43%)
Hyponatraemia	3 (.43%)
Intentional Overdose	3 (.43%)
Oedema	3 (.43%)
Pericardial Effusion	3 (.43%)
Posture Abnormal	3 (.43%)
Productive Cough	3 (.43%)
Psychomotor Hyperactivity	3 (.43%)
Pulmonary Fibrosis	3 (.43%)
Respiratory Arrest	3 (.43%)
Respiratory Disorder	3 (.43%)
Stereotypy	3 (.43%)
Visual Impairment	3 (.43%)
Vomiting	3 (.43%)
Alanine Aminotransferase Increased	2 (.28%)
Amaurosis	2 (.28%)
Aortic Valve Replacement	2 (.28%)
Aortic Valve Sclerosis	2 (.28%)
Aplasia	2 (.28%)
Arrhythmia	2 (.28%)
Aspartate Aminotransferase Increase...	2 (.28%)
Atrial Fibrillation	2 (.28%)
Blindness Transient	2 (.28%)
Blood Cholesterol Increased	2 (.28%)
Blood Creatine Phosphokinase Increa...	2 (.28%)
Blood Urea Increased	2 (.28%)
Bradykinesia	2 (.28%)
Bronchial Disorder	2 (.28%)
Bronchitis	2 (.28%)
Caesarean Section	2 (.28%)
Cardiac Disorder	2 (.28%)
Cardiac Failure Acute	2 (.28%)
Cardio-respiratory Arrest	2 (.28%)
Cervical Vertebral Fracture	2 (.28%)
Chest Pain	2 (.28%)
Chest X-ray Abnormal	2 (.28%)
Cheyne-stokes Respiration	2 (.28%)
Compulsive Shopping	2 (.28%)
Depressive Symptom	2 (.28%)
Disease Progression	2 (.28%)
Dysarthria	2 (.28%)
Dysphonia	2 (.28%)
Dyspnoea Exertional	2 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Cabaser, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cabaser is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cabaser

What are the most common Cabaser adverse events reported to the FDA?

Cardiac Valve	94 (13.33%)
Disturbances In Thinking	37 (5.25%)
Respiratory	37 (5.25%)
Pleural	35 (4.96%)
Lower Respiratory Tract Disorders	21 (2.98%)
Cardiac And Vascular Investigations	17 (2.41%)
Neurological	17 (2.41%)
Heart Failures	16 (2.27%)
Infections - Pathogen Unspecified	15 (2.13%)
Injuries	15 (2.13%)
Neuromuscular	15 (2.13%)
	Show More
Movement Disorders	14 (1.99%)
Personality Disorders	14 (1.99%)
Sleep Disorders	14 (1.99%)
Cardiac Arrhythmias	13 (1.84%)
Deliria	13 (1.84%)
Medication Errors	12 (1.7%)
Hematology Investigations	11 (1.56%)
Anxiety Disorders	10 (1.42%)
Impulse Control	10 (1.42%)
Sexual Function And Fertility	8 (1.13%)
Therapeutic And Nontherapeutic Effe...	8 (1.13%)
Vascular Hypertensive	8 (1.13%)
Vision	8 (1.13%)
Gastrointestinal Signs	7 (.99%)
Glucose Metabolism Disorders	7 (.99%)
Myocardial	7 (.99%)
Hepatobiliary	6 (.85%)
Lifestyle Issues	6 (.85%)
Muscle	6 (.85%)
Musculoskeletal And Connective Tiss...	6 (.85%)
Suicidal And Self-injurious Behavio...	6 (.85%)
Cardiac Disorder Signs	5 (.71%)
Epidermal And Dermal Conditions	5 (.71%)
Fatal Outcomes	5 (.71%)
Protein And Chemistry Analyses	5 (.71%)
Sleep Disturbances	5 (.71%)
Tissue	5 (.71%)
Bone And Joint Injuries	4 (.57%)
Changes In Physical Activity	4 (.57%)
Decreased And Nonspecific Blood Pre...	4 (.57%)
Electrolyte And Fluid Balance Condi...	4 (.57%)
Pericardial	4 (.57%)
Psychiatric And Behavioural Symptom...	4 (.57%)
Vascular	4 (.57%)
Body Temperature Conditions	3 (.43%)
Chemical Injury And Poisoning	3 (.43%)
Coronary Artery	3 (.43%)
Hemolyses And Related Conditions	3 (.43%)
Hepatic And Hepatobiliary	3 (.43%)
Renal And Urinary Tract Investigati...	3 (.43%)
Sexual Dysfunctions, Disturbances A...	3 (.43%)
Bacterial Infectious	2 (.28%)
Bronchial Disorders	2 (.28%)
Cardiac Therapeutic Procedures	2 (.28%)
Congenital And Hereditary	2 (.28%)
Depressed Mood Disorders	2 (.28%)
Endocrine Investigations	2 (.28%)
Enzyme	2 (.28%)
Hypothalamus And Pituitary Gland	2 (.28%)
Lipid Analyses	2 (.28%)
Mycobacterial Infectious	2 (.28%)
Neurological Disorders Congenital	2 (.28%)
Obstetric And Gynecological Therape...	2 (.28%)
Ocular Sensory Symptoms	2 (.28%)
Ocular Structural Change, Deposit A...	2 (.28%)
Oral Soft Tissue Conditions	2 (.28%)
Ovarian And Fallopian Tube	2 (.28%)
Physical Examination Topics	2 (.28%)
Platelet	2 (.28%)
Psychiatric	2 (.28%)
Pulmonary Vascular	2 (.28%)
Respiratory And Pulmonary Investiga...	2 (.28%)
Respiratory Disorders Congenital	2 (.28%)
Schizophrenia And Other Psychotic	2 (.28%)
Urinary Tract Signs	2 (.28%)
Allergic Conditions	1 (.14%)
Aural	1 (.14%)
Coagulopathies And Bleeding Diathes...	1 (.14%)
Communication Disorders	1 (.14%)
Cranial Nerve Disorders	1 (.14%)
Embolism And Thrombosis	1 (.14%)
Endocrine Neoplasms Benign	1 (.14%)
Eye	1 (.14%)
Fungal Infectious	1 (.14%)
Gastrointestinal Inflammatory Condi...	1 (.14%)
Gastrointestinal Motility And Defec...	1 (.14%)
Gastrointestinal Stenosis And Obstr...	1 (.14%)
Gastrointestinal Therapeutic Proced...	1 (.14%)
Gender Related Factors	1 (.14%)
Hearing	1 (.14%)
Investigations, Imaging And Histopa...	1 (.14%)
Joint	1 (.14%)
Lipid Metabolism	1 (.14%)
Lymphomas	1 (.14%)
Mental Impairment	1 (.14%)
Mesotheliomas	1 (.14%)
Metabolic, Nutritional And Blood Ga...	1 (.14%)
Miscellaneous And Site Unspecified ...	1 (.14%)
Mood Disorders	1 (.14%)
Ocular Neuromuscular	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cabaser, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cabaser is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.